Clover Corporation Limited (AU:CLV)
ASX:CLV
Top Page
Clover Corporation Limited
(Sydney:CLV)
Select Model
Select Model
Rating:72Outperform
Price Target:
AU$0.98
▲(22.75% Upside)
Action:ReiteratedDate:03/25/26
The score is primarily driven by strong financial performance (solid growth and profitability with minimal leverage), tempered by weakening free cash flow growth. Technicals are mixed—price trend is positive versus moving averages, but momentum indicators are subdued. Valuation is reasonable with a moderate P/E and modest yield.
Positive Factors
Revenue and margin growth
Consistent double-digit revenue growth (18.6%) combined with improved gross and net margins demonstrates durable demand for Clover’s products and effective cost control. Over 2–6 months this supports sustained cash generation potential and operational scalability.
Negative Factors
Decline in free cash flow growth
A steep drop in free cash flow growth reduces internal funding for capex, dividends or strategic investments. Even with decent FCF-to-net-income ratios, a sustained fall in cash conversion can constrain reinvestment and weaken liquidity cushions over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and margin growth
Consistent double-digit revenue growth (18.6%) combined with improved gross and net margins demonstrates durable demand for Clover’s products and effective cost control. Over 2–6 months this supports sustained cash generation potential and operational scalability.
Read all positive factors
Clover Corporation Limited (CLV) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$142.78M
Dividend Yield2.19%
Average Volume (3M)223.73K
Price to Earnings (P/E)7.7
Beta (1Y)0.02
Revenue Growth38.25%
EPS Growth361.54%
CountryAU
Employees60
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.03
Shares Outstanding166,999,340
10 Day Avg. Volume49,116
30 Day Avg. Volume223,729
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.28
Price to Sales (P/S)1.08
P/FCF Ratio13.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$89.40M
Clover Corporation Limited Business Overview & Revenue Model
Company Description
Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated products; and research and product development of functional food and infant nut...
How the Company Makes Money
null...
Clover Corporation Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.50M | 86.00M | 62.21M | 79.88M | 70.66M | 60.51M |
| Gross Profit | 30.77M | 26.17M | 16.86M | 23.74M | 21.66M | 18.24M |
| EBITDA | 15.20M | 12.24M | 3.98M | 10.01M | 11.66M | 10.23M |
| Net Income | 8.89M | 7.01M | 1.51M | 6.21M | 7.13M | 6.00M |
Balance Sheet | ||||||
| Total Assets | 86.98M | 86.80M | 84.39M | 86.20M | 90.77M | 78.73M |
| Cash, Cash Equivalents and Short-Term Investments | 10.27M | 8.68M | 12.26M | 9.44M | 10.11M | 9.09M |
| Total Debt | 1.26M | 2.42M | 10.39M | 11.71M | 12.08M | 14.19M |
| Total Liabilities | 13.69M | 14.57M | 17.32M | 19.05M | 27.73M | 20.32M |
| Stockholders Equity | 73.30M | 72.23M | 67.07M | 67.15M | 63.04M | 58.42M |
Cash Flow | ||||||
| Free Cash Flow | 2.96M | 6.95M | 6.13M | 5.10M | 4.51M | 6.40M |
| Operating Cash Flow | 4.47M | 8.29M | 8.45M | 6.74M | 5.93M | 8.23M |
| Investing Cash Flow | -1.51M | -1.34M | -2.97M | -2.53M | -1.43M | -1.83M |
| Financing Cash Flow | -8.07M | -10.52M | -2.66M | -4.88M | -3.49M | -6.55M |
Clover Corporation Limited Technical Analysis
Positive
0.80
Price Trends
0.77
Positive
0.77
Positive
0.67
Positive
Market Momentum
0.02
Negative
62.05
Neutral
75.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CLV, the sentiment is Positive. The current price of 0.8 is above the 20-day moving average (MA) of 0.79, above the 50-day MA of 0.77, and above the 200-day MA of 0.67, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 62.05 is Neutral, neither overbought nor oversold. The STOCH value of 75.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:CLV.
Clover Corporation Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | AU$142.78M | 7.66 | 10.01% | 2.19% | 38.25% | 361.54% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | AU$89.41M | 17.11 | 13.97% | ― | 28.66% | ― | |
50 Neutral | AU$28.23M | -2.06 | -41.69% | ― | 102.21% | 69.47% | |
42 Neutral | AU$5.66M | -0.01 | 226.76% | ― | -21.84% | 79.99% | |
40 Underperform | AU$26.02M | -5.27 | -19.17% | ― | 13.92% | 36.28% | |
39 Underperform | AU$23.17M | -33.08 | -321.20% | ― | 6.76% | ― |
* Consumer Defensive Sector Average
AU:CLV
Clover Corporation Limited
0.86
0.36
71.00%
AU:AHF
Australian Dairy Nutritionals Group
0.03
-0.02
-40.00%
AU:BUB
Bubs Australia Ltd.
0.10
-0.03
-23.08%
AU:NUC
Nuchev Pty Ltd
0.18
0.00
0.00%
AU:HCT
Holista Colltech Limited
0.06
0.03
103.23%
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
-0.01
-43.33%
Clover Corporation Limited Corporate Events
Clover Corporation Declares Interim Dividend of 1 Cent Per Share
Mar 23, 2026
Clover Corporation has declared a fully paid ordinary dividend of AUD 0.01 per share for the six-month period ended 31 January 2026. The dividend will trade ex-dividend on 15 April, with a record date of 16 April and payment scheduled for 30 April...
Clover lifts profit and margins on new products and demand rebound
Mar 23, 2026
Clover Corporation reported first-half FY26 revenue of $44.1 million, up $6.5 million on the prior corresponding period, driven by new customer acquisitions and higher contributions from existing clients. Gross margin strengthened to 35.6%, EBITDA...
Clover lifts profit, margins and sets bullish FY26 revenue guidance
Mar 23, 2026
Clover Corporation reported a strong first half for FY26, with revenue rising to $44.1 million and gross margin expanding to 35.6% on the back of favourable customer and product mix and solid manufacturing performance. EBITDA increased to $6.9 mil...
Clover Corporation Delivers Strong Half-Year Profit Growth and Maintains Dividend
Mar 23, 2026
Clover Corporation reported strong interim results for the half-year ended 31 January 2026, with revenue from ordinary activities rising 17% to $44.1 million and net profit after tax attributable to members increasing 90% to $4.2 million. Net prof...
Clover Corporation Sets Date for 1H FY26 Results and Investor Webinar
Mar 6, 2026
Clover Corporation Limited has announced that it will release its 1H FY26 financial results before the market opens on 24 March 2026. The company will host a webinar the same day, led by Managing Director and CEO Peter Davey and CFO Andrew Allibon...
Clover Corporation Issues Daily Update on Employee Share Buy-Back
Feb 19, 2026
Clover Corporation Limited, listed on the ASX under ticker CLV, manages a class of ordinary fully paid shares and engages in employee share scheme buy-backs as part of its equity and capital structure management. The company periodically reports o...
Clover Distances Itself from ARA Oil Contamination Behind Infant Formula Recalls
Feb 5, 2026
Clover Corporation Limited has moved to reassure the market that its products are not implicated in recent infant formula recalls linked to contamination in a batch of ARA (Arachidonic Acid) oil supplied by an unrelated third party. The company sa...
Clover Corporation Launches Employee Share Scheme Buy-Back
Jan 22, 2026
Clover Corporation Limited has announced an employee share scheme buy-back of its ordinary fully paid shares, indicating a capital management initiative focused on its staff equity programs. The move is expected to refine the company’s share...
Clover Corporation to On-Market Buy Back Shares for Employee Plan
Jan 22, 2026
Clover Corporation has instructed the trustee of its Employee Share Plan Trust to acquire up to 3,264,167 fully paid ordinary shares on-market over a period of up to 24 months to satisfy potential future vesting of Performance Rights granted betwe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.